Determination of optimum periods between onset of suspected acute myocarditis and 18F-fluorodeoxyglucose positron emission tomography in the diagnosis of inflammatory left ventricular myocardium

International Journal of Cardiology

Volumn 169, Issue 3, 2013, Pages 196-200

  Ozawa, Koya ^a   Funabashi, Nobusada ^a   Daimon, Michiko ^a   Takaoka, Hiroyuki ^a   Takano, Hiroyuki ^a   Uehara, Masae ^a   Kobayashi, Yoshio ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

18F fluorodeoxyglucose positron emission tomography; Acute myocarditis; Inflammatory left ventricular myocardium; Optimum periods

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GOLD STANDARD; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE BIOPSY; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INTERMETHOD COMPARISON; MALE; MYOCARDITIS; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

(18)F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY; ACUTE MYOCARDITIS; INFLAMMATORY LEFT VENTRICULAR MYOCARDIUM; OPTIMUM PERIODS;

ACUTE DISEASE; ADULT; AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HEART VENTRICLES; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MYOCARDITIS; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84887620844     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.08.098     Document Type: Article

References (12)

1. I. Kindermann, C. Barth, and F. Mahfoud Update on myocarditis J Am Coll Cardiol 59 2012 779 792
2. S. Mavrogeni, K. Bratis, and D. Georgakopoulos Evaluation of myocarditis in a pediatric population using cardiovascular magnetic resonance and endomyocardial biopsy Int J Cardiol 160 2012 192 195
3. L.T. Cooper, K.L. Baughman, and A.M. Feldman The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology J Am Coll Cardiol 50 2007 1914 1931
4. C.C. Deluigi, P. Ong, and S. Hill ECG findings in comparison to cardiovascular MR imaging in viral myocarditis Int J Cardiol 165 2013 100 106
5. P. Seizer, T. Geisler, and B. Bigalke EMMPRIN and its ligand Cyclophilin A as novel diagnostic markers in inflammatory cardiomyopathy Int J Cardiol 163 2013 299 304
6. A. Yilmaz, S. Rösch, and K. Klingel Magnetic resonance imaging (MRI) of inflamed myocardium using iron oxide nanoparticles in patients with acute myocardial infarction - preliminary results Int J Cardiol 163 2013 175 182
7. 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis Eur Heart J 26 2005 1538 1543
8. S. Miyazaki, N. Funabashi, and T. Nagai Cardiac sarcoidosis complicated with atrioventricular block and wall thinning, edema and fibrosis in left ventricle: confirmed recovery to normal sinus rhythm and visualization of edema improvement by administration of predonisolone Int J Cardiol 150 2011 e4 e10
9. H.T. Aretz, M.E. Billingham, and W.D. Edwards Myocarditis. A histopathologic definition and classification Am J Cardiovasc Pathol 1 1987 3 14
10. R. Kubota, S. Yamada, K. Kubota, K. Ishiwata, N. Tamahashi, and T. Ido Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography J Nucl Med 33 1992 1972 1980
11. 18F-fluorodeoxyglucose positron emission tomography Int J Cardiol 163 2013 277 281
12. ICRP Radiation dose to patients from radiopharmaceuticals. Addendum 3 to ICRP publication 53 ICRP publication 106 Ann ICRP 38 2008 1 197 [Approved by the Commission in October 2007]